Filing Details
- Accession Number:
- 0001181431-12-032552
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-24 19:12:44
- Reporting Period:
- 2012-05-22
- Filing Date:
- 2012-05-24
- Accepted Time:
- 2012-05-24 19:12:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327111 | Lynn Seely | C/O Medivation, Inc. 201 Spear Street, 3Rd Floor San Francisco CA 94105 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-22 | 12,500 | $13.47 | 34,011 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-05-22 | 12,500 | $88.51 | 21,511 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-05-22 | 12,500 | $0.00 | 12,500 | $13.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
37,500 | 2020-12-15 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 Plan.
- The shares were sold at prices ranging from $88.20 to $88.815. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on December 15, 2011, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) vest on the first day of each month thereafter.